Loading company…
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
ANGIOTENSIN THERAPEUTICS, INC. has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $909,941 between 2022 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Evanston, Illinois.
No investors recorded yet for ANGIOTENSIN THERAPEUTICS, INC..
Add an investorANGIOTENSIN THERAPEUTICS, INC. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for ANGIOTENSIN THERAPEUTICS, INC..
Add diversity data